Transversus abdominis plane block, intravenous lignocaine or placebo for postoperative analgesia after open prostate surgery: a randomized controlled trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2010-018321-20-BE

Enrollment

120

Registered

2015-08-25

Start date

2015-11-04

Completion date

Unknown

Last updated

2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate surgery

Interventions

Trade Name: Linisol Pharmaceutical Form: Solution for injection Pharmaceutical form of the placebo: Solution for injection Route of administration of the placebo: Intravenous drip use (Noncurrent) Tr

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Open prostate surgery Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 40 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 80

Exclusion criteria

Exclusion criteria: Allergy to study medication OSA Renal or liver failure Seizure Heart block

Design outcomes

Primary

Measure	Time frame
Main Objective: Compare the analgesic efficacy of TAP bloc, intravenous lidocaine and placebo after open prostate surgery;Secondary Objective: Not Applicable;Primary end point(s): Cumulative piritramide consumption after 48 hours;Timepoint(s) of evaluation of this end point: 48 hours	—

Secondary

Measure	Time frame
Secondary end point(s): Pain scores at rest and upon couging Bowel function recovery Nausea and vomiting Rescue analgesia Bladder catheter-related pain;Timepoint(s) of evaluation of this end point: hospital discharge	—

Countries

Belgium

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026